AzTrials
AzTrials

Rectal CancerNCT03013153

Low or High Ligation of the IMA With Apical Lymph Node Dissection in Rectal Cancer Laparoscopic Surgery

A study testing Low ligation with apical lymph node dissection and High ligation in people with Rectal Cancer, run by Sixth Affiliated Hospital, Sun Yat-sen University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Laparoscopy colon surgery is accepted worldwide in the recent years. But there is still argument on the effect of laparoscopy rectal surgery. Laparoscopy has advantages on showing the inferior mesenteric artery (IMA), protection of autonomic nerve, low rectal anastomosis, and total mesorectum excision. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Rectal Cancer
What is being tested?
Low ligation with apical lymph node dissection and High ligation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
748 participants
Where
1 siteChina
Study dates
Dec 2016to Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Pathology shows rectal or sigmoid adenocarcinoma
  • The bottom edge of tumor to anuas is less than 15cm
  • The clinical staging of tumor by American Joint Committee on Cancer (AJCC) within T2-4 or N1-2
  • Receive or not receive neoadjuvant chemotherapy based on 5-fluorouracil before surgery
  • Racial resection in available after neoadjuvant chemotherapy
  • No metastasis evidence was found
Show all 10Show fewer
  • Annual preservation surgery is available
  • Tolerate to general anesthesia
  • Eastern Cooperative Oncology Group (ECOG) status score between 0 and 1
  • Patients and general anesthesia can understand the clinical trail well and are willing to take part in

Who cannot join

  • Suffer with other carcinoma synchronous or metachronous in 5 years
  • Multiple primary colon carcinoma
  • Radiation therapy was performed before surgery
  • History of colorectal surgery
  • Combine with acute intestinal obstruction, intestinal bleeding, intestinal perforation and emergency surgery is needed
  • Multiple organs resection surgery is needed
Show all 13Show fewer
  • Abdominal perineal resection is performed
  • American Society of Anesthesiologists score stage IV to V
  • Pregnant, suckling period or reject to contraception
  • Severe cardiovascular disease, uncontrollable infection or other severe complication
  • Severe mental illness
  • Unable to go through the treatment because of family, society or regional condition
  • Refuse to take part in the trail

Trial locations and contacts

1 site in 1 country.

Jiaming Zhou, MD contact

+8613560031075

cysums03@163.com

Meijin Huang, MD contact

+8613924073322

13924073322@139.com

China1 site, 1 recruiting
  • The sixth affiliated hospital of Sun Yat-sen University

    Guangzhou, Guangdong, 510655

    Meijin Huang, MD, +8613924073322, 13924073322@139.com

    Jiaming Zhou, MD, +8613560031075, cysums03@163.com

    Recruiting

Other trials in China

About this study

Official title: Low or High Ligation of the Inferior Mesenteric Artery With Apical Lymph Node Dissection in Rectal Cancer Laparoscopic Surgery: A Prospective, Multi-Center, Randomized, Open-Label, Parallel Group, Non-Inferiority Clinical Trial (LAND)

Laparoscopy colon surgery is accepted worldwide in the recent years. But there is still argument on the effect of laparoscopy rectal surgery. Laparoscopy has advantages on showing the inferior mesenteric artery (IMA), protection of autonomic nerve, low rectal anastomosis, and total mesorectum excision. However, debate on the level of IMA ligation and debonding of splenic flexure never ends. This study is going to give a clear and definite answer to how and why surgeons should deal with the IMA in laparoscopy rectal surgery,base on the 3D reconstruction of IMA and identification of IMA perfusion types.

Read the detailed description

According to the report of World Health Organization 2015, the morbility and mortality of colorectal cancer (CRC) are rising all over the world. Although the technique gets great approval in CRC surgical treatment in the recent years, such as TME protocol, neoadjuvant and laparoscopy technique, the complication of anastomosis leakage and nerve damage are still to be solved.

Laparoscopy colon surgery is accepted worldwide in the recent years. But there is still argument on the effect of laparoscopy rectal surgery. Laparoscopy has advantages on showing the inferior mesenteric artery, protection of autonomic nerve, low rectal anastomosis, and total mesorectum excision. However, debate on where is the best level of IMA ligation and whether splenic flexure be debonded never ends. This study is going to give a clear and definite answer to how and why surgeons should deal with the IMA in laparoscopy rectal surgery.

The ligation level of IMA affects on hypogastric and pelvic nerve, leads to disorder of sexual and urination functions. What's more, it also have affection on the apical lymph node (No.253) harvesting and the blood supplement of proximal colon. Former studies have proved that the blood supplement and tension of anastomosis leads to leakage after surgery. Meanwhile, the ligation level of IMA is the key point on it.

The former study comes from the sixth affiliated hospital found that the mistake of ligation level of IMA happened because of the poor touching and explosion with laparoscopy. The distance from the root of IMA to left colic artery (DRL) vary between 19mm and 64mm. When surgeon made mistake during ligation, it led to the insufficient resection of apical lymph node. Further more, affect the long-term survival. Besides, there are 4 different types of IMA according to the relationship between the left colic artery, sigmoid artery and superior rectal artery. These branches will confuse surgeon on how to deal with them. 3D reconstruction of abdominal pelvic CT is able to show the length of DRL, IMA types and apical lymph nodes clearly. With these technique, the investigators can preserve the left colic artery and resect apical lymph nodes precisely.

In the past studies, high or low ligation takes advantage on both side. But none of them comes from retrospective clinical trail. Some author believe that high ligation do better in resection of apical lymph nodes, release the tension of anastomosis, providing precise tumor staging. On the other side, some authors consider that high ligation may cut down blood supplement, rise the incident of anastomosis leakage (AL). so they prefer low ligation to the high. Some studies show that there are no long term survival difference between high and low ligation on IMA in laparoscopy rectal resection. So whether high ligation is necessary, still to be proved.

For local advanced rectal cancer, neoadjuvant chemotherapy can lesson tumor size, reduce recurrence, preserve annual better and rise long-term survival. National Comprehensive Cancer Network command chemotherapy before surgery (Total Mesorectal Excision TME) as the standard for rectal cancer since 2005. Another randomized controlled trial (RCT) named Neoadjuvant FOLFOX6 Chemotherapy With or Without Radiation in Rectal Cancer (FOWARC) NCT01211210 has proved the recent positive result. In those cases, the positive metastasis apical lymph node appeared in less than 5% (5/116) cases. On the other side, the incident of AL was up to 7% (8/116) . This phenomenon discover that maybe low ligation with apical lymph nodes dissection can get the same treatment effect and decrease AL from happening.

Conditions
Rectal Cancer
Being tested
Low ligation with apical lymph node dissection, High ligation
Keywords
Rectal Cancer, Inferior Mesenteric Artery, Ligation, Apical Lymph Nodes, Laparoscopy, IMA Types
Medical subject headings
Rectal Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Low ligation with apical lymph node dissectionProcedure or surgery

    Also called LAND

    Low ligation with apical lymph node dissection (LAND). Left colic artery (LCA) is identified according to the CT 3D-reconstruction, tie the sigmoid artery and superior rectal artery, preserved LCA while low ligation of the inferior mesenteric artery is performed. Lymphadenectomy to the apical lymph nodes (No.253)is performed around the IMA until 2 cm from the aorta.

  • High ligationProcedure or surgery

    Also called HL

    High ligation (HL) Open the peritoneum proceeds cephalad towards the duodenojejunal angle of Treitz, and the mesenteric root is incised 1 cm below the inferior margin of the pancreas. The aortomesenteric window is opened wide and the inferior mesenteric vessels are exposed. The IMA is ligated and divided at 2 cm from its origin. The inferior mesenteric vein (IMV) is divided and ligated below the pancreatic margin.

Study groups in NCT03013153
Study groupRoleWhat they receive
Low ligation with apical lymph node dissectionExperimentalLeft colic artery (LCA) is identified according to the CT 3D-reconstruction, tie the sigmoid artery and superior rectal artery, preserved LCA while low ligation of the inferior mesenteric artery is performed. Lymphadenectomy to the apical lymph nodes (No.253)is performed around the IMA until 2 cm from the aorta. The inferior mesenteric vein (IMV) is divided and ligated below the pancreatic margin.
Receives: Procedure: Low ligation with apical lymph node dissection
High ligationActive comparatorOpen the peritoneum proceeds cephalad towards the duodenojejunal angle of Treitz, and the mesenteric root is incised 1 cm below the inferior margin of the pancreas. The aortomesenteric window is opened wide and the inferior mesenteric vessels are exposed. The IMA is ligated and divided at 2 cm from its origin. The inferior mesenteric vein (IMV) is divided and ligated below the pancreatic margin.
Receives: Procedure: High ligation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 5-years overall survival rate

    5-years overall survival rate

    Measured: 5 years

Secondary outcomes (23)
  1. 5-years disease free survival rate

    5-years disease free survival rate

    Measured: 5 years

  2. 1-year overall survival rate

    1-year overall survival rate

    Measured: 1 year

  3. 1-year disease free survival rate

    1-year disease free survival rate

    Measured: 1 year

  4. Anastomosis leakage rate

    anastomosis leakage rate after surgery, acute or chronic

    Measured: 6 months

  5. Apical Lymph Nodes (LN) Positive Rate

    Apical Lymph Nodes Positive Rate, No.253 LN

    Measured: 1 week

  6. Operation Time

    Measured: 1 day

  7. Blood loss during operation

    Measured: 1 day

  8. Complication incident rate of surgery

    Measured: 1 day

  9. conversion rate to laparotomy

    Measured: 1 day

  10. Identification of IMA perfusion type before surgery

    Measured: 1 day

  11. Identification of lymph node metastasis by CT

    Measured: 7 days

  12. Mortality rate in 30 days after surgery

    Measured: 30 days

  13. Recovery time after surgery

    Measured: 60 days

  14. White cell level

    Measured: 7 days

  15. C-reaction protein level

    Measured: 7 days

  16. Albumin level

    Measured: 7 days

  17. Anastomosis bleeding rate after surgery

    Measured: 30 days

  18. Anastomosis stenosis rate after surgery

    Measured: 30 days

  19. Intestinal dysfunction after stoma closure

    Measured: 1 year

  20. Anus function after surgery

    Measured: 1 year

  21. Life quality scoring

    Measured: 1 year

  22. Bladder residual urine volume

    Measured: 1 year

  23. Sexual function scoring

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jan 2017 (estimated)
  2. Study startDec 2016
  3. Primary completionDec 2018 (estimated)
  4. Study completionDec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
748 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03013153
Sponsor's protocol ID
LAND
Status last verified
Dec 2016
First submitted
31 Dec 2016
Last updated
12 Jan 2017
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Yes

Publications

  • Mari G, Maggioni D, Costanzi A, Miranda A, Rigamonti L, Crippa J, Magistro C, Di Lernia S, Forgione A, Carnevali P, Nichelatti M, Carzaniga P, Valenti F, Rovagnati M, Berselli M, Cocozza E, Livraghi L, Origi M, Scandroglio I, Roscio F, De Luca A, Ferrari G, Pugliese R. "High or low Inferior Mesenteric Artery ligation in Laparoscopic low Anterior Resection: study protocol for a randomized controlled trial" (HIGHLOW trial). Trials. 2015 Jan 27;16:21. doi: 10.1186/s13063-014-0537-5.

    PubMed 25623323
  • Bostrom P, Haapamaki MM, Matthiessen P, Ljung R, Rutegard J, Rutegard M. High arterial ligation and risk of anastomotic leakage in anterior resection for rectal cancer in patients with increased cardiovascular risk. Colorectal Dis. 2015 Nov;17(11):1018-27. doi: 10.1111/codi.12971.

    PubMed 25851151
  • Tanaka J, Nishikawa T, Tanaka T, Kiyomatsu T, Hata K, Kawai K, Kazama S, Nozawa H, Yamaguchi H, Ishihara S, Sunami E, Kitayama J, Watanabe T. Analysis of anastomotic leakage after rectal surgery: A case-control study. Ann Med Surg (Lond). 2015 May 11;4(2):183-6. doi: 10.1016/j.amsu.2015.05.002. eCollection 2015 Jun.

    PubMed 26042185
  • Dauser B, Herbst F. Diagnosis, management and outcome of early anastomotic leakage following colorectal anastomosis using a compression device: is it different? Colorectal Dis. 2014 Dec;16(12):O435-9. doi: 10.1111/codi.12742.

    PubMed 25132419
  • GRIFFITHS JD. Surgical anatomy of the blood supply of the distal colon. Ann R Coll Surg Engl. 1956 Oct;19(4):241-56. No abstract available.

    PubMed 13363265
  • Masoni L, Mari FS, Nigri G, Favi F, Gasparrini M, Dall'Oglio A, Pindozzi F, Pancaldi A, Brescia A. Preservation of the inferior mesenteric artery via laparoscopic sigmoid colectomy performed for diverticular disease: real benefit or technical challenge: a randomized controlled clinical trial. Surg Endosc. 2013 Jan;27(1):199-206. doi: 10.1007/s00464-012-2420-3. Epub 2012 Jun 26.

    PubMed 22733197
  • Hida J, Okuno K. High ligation of the inferior mesenteric artery in rectal cancer surgery. Surg Today. 2013 Jan;43(1):8-19. doi: 10.1007/s00595-012-0359-6. Epub 2012 Oct 7.

    PubMed 23052748
  • Murono K, Kawai K, Kazama S, Ishihara S, Yamaguchi H, Sunami E, Kitayama J, Watanabe T. Anatomy of the inferior mesenteric artery evaluated using 3-dimensional CT angiography. Dis Colon Rectum. 2015 Feb;58(2):214-9. doi: 10.1097/DCR.0000000000000285.

    PubMed 25585080
  • Seike K, Koda K, Saito N, Oda K, Kosugi C, Shimizu K, Miyazaki M. Laser Doppler assessment of the influence of division at the root of the inferior mesenteric artery on anastomotic blood flow in rectosigmoid cancer surgery. Int J Colorectal Dis. 2007 Jun;22(6):689-97. doi: 10.1007/s00384-006-0221-7. Epub 2006 Nov 3.

    PubMed 17082922
  • Battal B, Hamcan S, Akgun V, Bozkurt Y. Congenital superior-inferior mesenteric arterial variation or arc of Riolan due to occlusion of proximal superior mesenteric artery. Surg Radiol Anat. 2014 Apr;36(3):309-10. doi: 10.1007/s00276-013-1212-3. Epub 2013 Oct 18. No abstract available.

    PubMed 24135762
  • van Gulik TM, Schoots I. Anastomosis of Riolan revisited: the meandering mesenteric artery. Arch Surg. 2005 Dec;140(12):1225-9. doi: 10.1001/archsurg.140.12.1225.

    PubMed 16365247
  • Bertrand MM, Delmond L, Mazars R, Ripoche J, Macri F, Prudhomme M. Is low tie ligation truly reproducible in colorectal cancer surgery? Anatomical study of the inferior mesenteric artery division branches. Surg Radiol Anat. 2014 Dec;36(10):1057-62. doi: 10.1007/s00276-014-1281-y. Epub 2014 Mar 15.

    PubMed 24633578
  • Trencheva K, Morrissey KP, Wells M, Mancuso CA, Lee SW, Sonoda T, Michelassi F, Charlson ME, Milsom JW. Identifying important predictors for anastomotic leak after colon and rectal resection: prospective study on 616 patients. Ann Surg. 2013 Jan;257(1):108-13. doi: 10.1097/SLA.0b013e318262a6cd.

    PubMed 22968068
  • Hirst NA, Tiernan JP, Millner PA, Jayne DG. Systematic review of methods to predict and detect anastomotic leakage in colorectal surgery. Colorectal Dis. 2014 Feb;16(2):95-109. doi: 10.1111/codi.12411.

    PubMed 23992097
  • Silberhumer GR, Paty PB, Temple LK, Araujo RL, Denton B, Gonen M, Nash GM, Allen PJ, DeMatteo RP, Guillem J, Weiser MR, D'Angelica MI, Jarnagin WR, Wong DW, Fong Y. Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure. Am J Surg. 2015 Jun;209(6):935-42. doi: 10.1016/j.amjsurg.2014.09.024. Epub 2014 Dec 13.

    PubMed 25601556

Questions about this trial

What is this clinical trial studying?

A study testing Low ligation with apical lymph node dissection and High ligation in people with Rectal Cancer, run by Sixth Affiliated Hospital, Sun Yat-sen University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Jan 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jiaming Zhou, MD (+8613560031075, cysums03@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

5-years overall survival rate (time frame: 5 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03013153, which also lists 23 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jan 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in